Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204228 · ClinicalTrials.gov registry record
TITAN™ Reverse Shoulder System
A clinical trial, sponsored by Smith & Nephew.
- Terminated
- Registry status
- 151
- Enrollment target
NCT02204228: Clinical Trial study, sponsored by Smith & Nephew.
NCT02204228 is a clinical trial that was terminated before completion, run by Smith & Nephew. The registered enrollment target is 151 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02204228 was terminated before completion, sponsored by Smith & Nephew.
- TERMINATED
- Registry status
- 151 participants
- Enrollment target
Study Summary
The Integra® TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct. When used under the conditions and purposes intended the TRS will relieve pain and restore some functional joint motion to the affected shoulder. The purpose of this study is to assess the short, mid and long term outcomes of the TITAN™ Reverse Shoulder System.
Primary Outcome
Any implant revisions or device related adverse events must be reported as soon as the event is discovered. Assessment of adverse events will occur at each clinic visit.
Interventions
- DEVICE TITAN™ Reverse Shoulder System (TRS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2014-09 |
| Est. Completion | 2023-12-14 |
Why NCT02204228 stopped before completion
NCT02204228 is an observational study that tracks outcomes without assigning an intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which TITAN™ Reverse Shoulder System (TRS) is the first listed.
NCT02204228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02204228 about?
NCT02204228 is a clinical study titled "TITAN™ Reverse Shoulder System". The Integra® TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct. When used under the conditions and purposes intended the TRS will relieve pain and restore some functional joint motion to the affected shoulder. The purpose of this study is to assess the short, mid an...
What is the current status of trial NCT02204228?
This trial is currently terminated. The enrollment target is 151 participants. The study started on 2014-09. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT02204228?
The interventions under investigation include: TITAN™ Reverse Shoulder System (TRS) (DEVICE).
Who is sponsoring clinical trial NCT02204228?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia